Angelis A, Tordrup D and Kanavos P 2015 Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health Policy. 119 964–979

Barohn RJ, Dimachkie MM and Jackson CE 2014 A pattern recognition approach to patients with a suspected myopathy. Neurol. Clin. 32 569–593

Article  PubMed  PubMed Central  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM, et al. 2018 Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17 347–361

Article  PubMed  PubMed Central  Google Scholar 

Bosch AM, Stroek K, Abeling NG, et al. 2012 The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J. Rare Dis. 7 83

Article  PubMed  PubMed Central  Google Scholar 

Chu ML and Moran E 2018 The limb-girdle muscular dystrophies: Is treatment on the horizon? Neurotherapeutics 4 849–862

Article  Google Scholar 

Dowling JJ, Gonorazky DH, Cohn RD, et al. 2017 Treating paediatric neuromuscular disorders: The future is now. Am. J. Med. Genet. A 176 804–841

Article  PubMed  PubMed Central  Google Scholar 

Emery AE 1991 Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul. Disord. 1 19–29

Article  CAS  PubMed  Google Scholar 

Engel AG, Shen XM, Selcen D, et al. 2015 Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 14 420–434

Article  PubMed  PubMed Central  Google Scholar 

Ferreira CR 2019 The burden of rare diseases. Am. J. Med. Genet. A 179 885–892

Article  PubMed  Google Scholar 

Gineste C and Laporte J 2023 Therapeutic approaches in different congenital myopathies. Curr. Opin. Pharmacol. 68 102328

Article  CAS  PubMed  Google Scholar 

Hall JG, Powers EK, Mcllvaine RT, et al. 1978 The frequency and financial burden of genetic disease in a paediatric hospital. Am. J. Med. Genet. 1 417–436

Article  CAS  PubMed  Google Scholar 

Heron M 2018 Deaths: Leading causes for 2016. Natl. Vital Stat. Rep. 67 1–77

PubMed  Google Scholar 

Jackson CE 2008 A clinical approach to muscle diseases. Semin. Neurol. 28 228–240

Article  PubMed  Google Scholar 

Katragadda S, Hall TO, Bettadapura R, et al. 2021 Determining cost-optimal next-generation sequencing panels for rare disease and pharmacogenomics testing. Clin. Chem. 67 1122–1132

Article  PubMed  Google Scholar 

Matthews E, Brassington R, Kuntzer T, et al. 2016 Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst. Rev. 5 CD003725

Google Scholar 

McDonald CM 2012 Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. Phys. Med. Rehabil. Clin. N. Am. 23 495–563

Article  PubMed  PubMed Central  Google Scholar 

National Policy for Rare Disease, NPRD 2021 https://main.mohfw.gov.in/sites/default/files/Final%20NPRD%2C%202021.pdf

National Organization for Rase Disease, NORD 2023 Rare disease database https://rarediseases.org/rare-diseases/

Orphanet Report Series – Prevalence of rare diseases: Bibliographic data 2022 http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_diseases.pdf

Pasnoor M and Dimachkie MM 2019 Approach to muscle and neuromuscular junction disorders. Continuum 25 1536–1563

PubMed  Google Scholar 

Pisciotta C, Saveri P and Pareyson D 2021 Challenges in treating Charcot-Marie-Tooth disease and related neuropathies: current management and future perspectives. Brain Sci. 11 1447

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricci FS, D’Alessandro R, Vacchetti M, et al. 2022 Improving recognition of treatable rare neuromuscular disorders in primary care: A pilot feasibility study. Children 9 1063

Article  PubMed  PubMed Central  Google Scholar 

Schorling DC, Pechmann A and Kirschner J 2020 Advances in treatment of spinal muscular atrophy - new phenotypes, new challenges, new implications for care. J. Neuromuscul. Dis. 7 1–13

Article  PubMed  PubMed Central  Google Scholar 

Soneda A, Teruya H, Furuya N, et al. 2012 Proportion of malformations and genetic disorders among cases encountered at a high-care unit in a children’s hospital. Eur. J. Pediatr. 171 301–305

Article  PubMed  Google Scholar 

Statland JM and Barohn RJ 2013 Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. Continuum 19 1598–1614

PubMed  PubMed Central  Google Scholar 

Strehle EM 2009 Long-term management of children with neuromuscular disorders. J. Pediatr. 85 379–384

Article  Google Scholar 

Suthar R and Patil AN 2021 Spinal muscular atrophy therapeutics in India: Parental hopes and despair! Ann. Neurosci. 28 112–113

Article  PubMed  PubMed Central  Google Scholar 

Swaminathan S, Hemalatha R, Pandey A, et al. 2019 The burden of child and maternal malnutrition and trends in its indicators in the states of India: the Global Burden of Disease Study 1990–2017. Lancet Child Adolesc. Health 3 855–870

Article  Google Scholar 

Teoh HL, Sampaio H, Roscioli T, et al. 2016 Approaches to genetic diagnosis in neuromuscular conditions in the era of next generation sequencing. J. Neurol. Neurosurg. Psychiatry 87 1384–1385

Article  PubMed  Google Scholar 

The Drugs and Cosmetics Act, 1940 (23 of 1940) and the Drugs and Cosmetics Rules 1945. 2016. https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf

World Health Organization 2022 ICD-11: International classification of diseases. https://icd.who.int/

Yao S, Chen Z, Yu Y, et al. 2021 Current pharmacological strategies for Duchenne muscular dystrophy. Front. Cell Dev. Biol. 9 689533

Article  PubMed  PubMed Central  Google Scholar 

Yasha TC, Sharma S, Gayathri N, et al. 2022 Hereditary neuropathies: Genetics and utility of nerve biopsy. Indian J. Pathol. Microbiol. 65 318–328

Google Scholar 

Yoon PW, Olney RS, Khoury MJ, et al. 1997 Contribution of birth defects and genetic diseases to paediatric hospitalizations. A population-based study. Arch. Pediatr. Adolesc. Med. 15 1096–1103

Article  Google Scholar